Angelini Ventures
Dr. Regina Hodits appointed Managing Director at Angelini Ventures to advance international BioTech strategy
Angelini Ventures is pleased to announce the appointment of Dr. Regina Hodits as Managing Director.
A highly respected figure in the European biotech investment landscape, Dr. Hodits brings over two decades of venture capital experience and an exceptional track record in company building and strategic exits.
Based in Germany, Dr. Hodits will play a pivotal role in defining Angelini Ventures' international BioTech investment strategy, working alongside the existing leadership team to identify breakthrough innovations across therapeutics and biotech AI.
This strategic appointment reflects Angelini Ventures commitment to expanding its global presence and investment capabilities.
Regina's scientific depth, extensive investment experience and exceptional track record in company-building make her a key addition to Angelini Ventures
Paolo Di Giorgio,
Angelini Ventures is building something truly unique in the life sciences ecosystem. I'm excited to work jointly with the colleagues at Angelini Ventures and to leverage the combined extensive network - spanning founders, investors and academic leaders - to build the next generation of biotech leaders and help scale great science into impactful companies.
Regina Hodits,